Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 with tumor dedifferentiation in hepatocellular carcinomas

被引:46
|
作者
Ogata, R
Torimura, T
Kin, M
Ueno, T
Tateishi, Y
Kuromatsu, R
Shimauchi, Y
Sakamoto, M
Tamaki, S
Sata, M
Tanikawa, K
机构
[1] Kurume Univ, Sch Med, Dept Med 2, Kurume, Fukuoka 8300011, Japan
[2] Res Innovat Canc Therapy, Liver Canc Res Div, Kurume, Fukuoka, Japan
[3] Kurume Res Ctr, Int Inst Liver Res, Kurume, Fukuoka, Japan
关键词
MT-MMP; MMP-2; HCC; immunohistochemistry; in situ hybridization; gelatin zymography;
D O I
10.1016/S0046-8177(99)90121-1
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Destruction of the extracellular matrices is required for tumor invasion and metastasis. Matrix metalloproteinase-2 degrades type IV collagen and laminin, major components of the basement membrane. Membrane type 1 matrix metalloproteinase activates the latent form of matrix metalloproteinase-2. We studied changes in membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 expression in relation to the tumor differentiation of hepatocellular carcinomas. Activity of matrix metalloproteinase-2 was also evaluated in hepatocellular carcinomas and noncancerous tissues. Overall, 37 hepatocellular carcinomas were studied. Expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 was determined by either immunohistochemistry (n = 37) or in situ hybridization (n = 6). Changes in membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 expression were evaluated in relation to tumor differentiation. Gelatinolytic activities were analyzed by gelatin zymography (n = 4). Membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 were detected in hepatoma cells and stromal cells. In addition, these matrix metalloaro-teinases were detected in the same hepatoma cells. Increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 was associated with tumor dedifferentiation. The active form of matrix metalloproteinase-2 was more strongly expressed by hepatocellular carcinomas than by noncancerous tissues. These findings indicate that increased expression of membrane type 1 matrix metalloproteinase and matrix metalloproteinase-2 was associated with tumor dedifferentiation, suggesting that these matrix metalloproteinases are intimately involved in the invasion of hepatocellular carcinomas. Copyright (C) 1999 by W.B. Saunders Company.
引用
收藏
页码:443 / 450
页数:8
相关论文
共 50 条
  • [1] Increased expression of membrane-type 1 matrix metalloproteinase and matrix metalloproteinase-2 is associated with tumor development in hepatocellular carcinoma.
    Tsuji, R
    Torimura, T
    Kin, M
    Tateishi, Y
    Ono, N
    Ueno, T
    Sata, M
    Tanikawa, K
    [J]. GASTROENTEROLOGY, 1997, 112 (04) : A1404 - A1404
  • [2] Expression of membrane-type-1-matrix metalloproteinase and metalloproteinase-2 in nonsmall cell lung carcinomas
    Yamamura, T
    Nakanishi, K
    Hiroi, S
    Kumaki, F
    Sato, H
    Aida, S
    Kawai, T
    [J]. LUNG CANCER, 2002, 35 (03) : 249 - 255
  • [3] Increased matrix metalloproteinase-2 and membrane type 1 matrix metalloproteinase activity and expression in heterotopically transplanted murine tracheas
    Inaki, N
    Tsunezuka, Y
    Kawakami, K
    Sato, H
    Takino, T
    Oda, M
    Watanabe, G
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2004, 23 (02): : 218 - 227
  • [4] Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase
    Schwartz, JD
    Shamamian, P
    Monea, S
    Whiting, D
    Marcus, SG
    Galloway, AC
    Mignatti, P
    [J]. SURGERY, 1998, 124 (02) : 232 - 238
  • [5] Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines
    Afzal, S
    Lalani, EN
    Foulkes, WD
    Boyce, B
    Tickle, S
    Cardillo, MR
    Baker, T
    Pignatelli, M
    Stamp, GWH
    [J]. LABORATORY INVESTIGATION, 1996, 74 (02) : 406 - 421
  • [6] Dual expression of matrix metalloproteinase-2 and membrane-type 1 - Matrix metalloproteinase in fibrotic human livers
    Takahara, T
    Furui, K
    Yata, Y
    Jin, B
    Zhang, LP
    Nambu, S
    Sato, H
    Seiki, M
    Watanabe, A
    [J]. HEPATOLOGY, 1997, 26 (06) : 1521 - 1529
  • [7] Expression of matrix metalloproteinase-2 and tissue inhibitor of matrix metalloproteinase-2 in oral squamous cell carcinomas
    Radhakrishnan, R.
    Shrestha, B.
    Bajracharya, D.
    [J]. ORAL ONCOLOGY, 2011, 47 : S84 - S84
  • [8] Activation of tumor cell matrix metalloproteinase-2 by neutrophil proteinases requires expression of membrane-type 1 matrix metalloproteinase - Discussion
    Nackman, GB
    Schwartz
    [J]. SURGERY, 1998, 124 (02) : 238 - 238
  • [9] Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium
    Chung, HW
    Lee, JY
    Moon, HS
    Hur, SE
    Park, MH
    Wen, Y
    Polan, ML
    [J]. FERTILITY AND STERILITY, 2002, 78 (04) : 787 - 795
  • [10] Increased expression of matrix metalloproteinase 7 and 9 and membrane type 1-matrix metalloproteinase in esophageal squamous cell carcinomas
    Ohashi, K
    Nemoto, T
    Nakamura, K
    Nemori, R
    [J]. CANCER, 2000, 88 (10) : 2201 - 2209